-transparent.png){kind=logo}
The characteristics of pirarubicin transport have been investigated in polymorphonuclear leukocytes isolated from rats. The uptake of pirarubicin by leukocytes was time-, temperature- and concentration-dependent with the maximum velocity (Vmax) of 4.84 nmol/5 x 10(6) cells/min and the Michaelis constant (Km) of 13.4 microM. The uptake depended on the extracellular pH, indicating that the molecular form of pirarubicin is more permeable than its ionic form and/or that the transporter of pirarubicin has optimal pH range. When the intracellular space was changed by increasing the medium osmolarity with sucrose, the uptake was altered by osmolarity changes and it appeared that about 27% of the drug was bound to the membrane surface. The initial uptake was inhibited by the metabolic inhibitors rotenone, 2,4-dinitrophenol and sodium cyanide. Pirarubicin accumulation in the intracellular glucose-depleted cells diminished significantly compared with that in normal cells. The efflux of pirarubicin from leukocytes was also temperature-dependent and inhibited by a metabolic inhibitor. These results indicate that a specific mechanism is concerned in the transport of pirarubicin in polymorphonuclear leukocytes.
K Nagasawa, and
M Nomiyama, and
N Ohnishi, and
T Yokoyama, and
S Iwakawa, and
K Okumura
January 1982,
Advances in experimental medicine and biology,
K Nagasawa, and
M Nomiyama, and
N Ohnishi, and
T Yokoyama, and
S Iwakawa, and
K Okumura
March 1969,
Biochimica et biophysica acta,
K Nagasawa, and
M Nomiyama, and
N Ohnishi, and
T Yokoyama, and
S Iwakawa, and
K Okumura
January 2002,
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
K Nagasawa, and
M Nomiyama, and
N Ohnishi, and
T Yokoyama, and
S Iwakawa, and
K Okumura
July 1990,
Pediatric research,
K Nagasawa, and
M Nomiyama, and
N Ohnishi, and
T Yokoyama, and
S Iwakawa, and
K Okumura
March 2005,
Cancer chemotherapy and pharmacology,
K Nagasawa, and
M Nomiyama, and
N Ohnishi, and
T Yokoyama, and
S Iwakawa, and
K Okumura
May 1981,
Biochimica et biophysica acta,
K Nagasawa, and
M Nomiyama, and
N Ohnishi, and
T Yokoyama, and
S Iwakawa, and
K Okumura
November 2001,
International journal of antimicrobial agents,
K Nagasawa, and
M Nomiyama, and
N Ohnishi, and
T Yokoyama, and
S Iwakawa, and
K Okumura
January 1972,
Biochimica et biophysica acta,
K Nagasawa, and
M Nomiyama, and
N Ohnishi, and
T Yokoyama, and
S Iwakawa, and
K Okumura
May 2002,
The Journal of infectious diseases,
K Nagasawa, and
M Nomiyama, and
N Ohnishi, and
T Yokoyama, and
S Iwakawa, and
K Okumura
January 1990,
Journal of inherited metabolic disease,
